Home » Topics » BioWorld Science

BioWorld Science
RSS

New anti-herpes virus agents discovered by GSK team

May 27, 2004

Aventis claims glucose lowering agents for type 2 diabetes and other disorders

May 27, 2004

Novel antitumor podophyllotoxins developed by Plantaceutica researchers

May 27, 2004

New adenosine A2A antagonists for PD, depression, dementia, etc.

May 27, 2004

Roche presents pegylated IGFBP-4 conjugates and their use in cancer therapy

May 27, 2004

Arena develops antilipolytic agents targeting the nicotinic acid RUP25 receptor

May 27, 2004

Selective calcium channel inhibitor blocks hyperalgesia effectively in vivo

May 27, 2004

Benefits associated with IB-MECA in a model of experimental colitis

May 27, 2004

Enrollment completed in ADHD phase II study of NS-2359

May 27, 2004

Pexelizumab reduces events in patients undergoing CABG

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...